Memed
Brazil, São Paulo, SP
About Memed
Memed is a Brazilian healthtech that runs the country's leading digital medical prescription platform, used by roughly 150,000 doctors a month and generating around 100 million e-prescriptions a year. Beyond prescriptions, it is building AI-driven clinical tools — drug-interaction and dosage alerts, patient guidance, and integrations with electronic health records and hospital systems — to become core infrastructure for digitizing Brazilian healthcare. The company reached breakeven in mid-2025, largely by helping the pharmaceutical industry communicate with physicians, and holds about a 60% share among doctors who prescribe digitally.
Latest Funding
Series AAnnounced 2026-05-21
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
3 signals · where the capital is going
Hiring new technology and product staff; headcount grew from 90 to 160 over the past year with plans to reach 180 by year-end, focused on AI and healthcare expe…
valorinternational.globo.com
+2 more capital deployment signals · confidence ratings · source articles
Sign up freeIn the news
Selling to Memed? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Memed.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of Memed, and who are their main competitors?
Sign up free to ask AI about Memed
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
DGF Investimentos
Lead investor · Series A
Tech Stack
Key Highlights
AI InsightsReached breakeven in mid-2025 after 13 years of losses and is now profitable, projecting roughly R$100 million in revenue for 2026.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Memed
Selling to Memed? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Memed.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.